The role of the Merrifield solid phase method in the discovery and exploration of a new class of selective vasopressin hypotensive agonists

International Journal of Peptide Research and Therapeutics

Volumn 13, Issue 1-2, 2007, Pages 7-17

  Manning, Maurice ^a   Stoev, Stoytcho ^a   Cheng, Ling Ling ^a   Wo, Nga ^b   Chan, W Y ^b   Szeto, Hazel H ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Hypotensive peptides; Solid phase synthesis; Vasopressin

Indexed keywords

ANTIHYPERTENSIVE AGENT; OXYTOCIN; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN AGONIST; VASOPRESSIN RECEPTOR;

ANALYTIC METHOD; ARTICLE; HORMONE SYNTHESIS; MERRIFIELD SOLID PHASE METHOD; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 34250020493     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-007-9089-9     Document Type: Article

References (59)

1. Barberis C. M., Morin D., Durroux T., Mouillac B., Guillon G., Seyer R., Hibert M., Tribollet E., Manning M. (1999) Drug News Perspect. 12(5): 279-292
2. Bernatowicz M. S., Wu Y., Matsueda G. R. (1992) J. Org. Chem. 57: 2497-2502
3. Berde, B. and Boissonnas, R. A.: 1968, in B. Berde (ed.), Handbook of Experimental Pharmacology, Springer-Verlag, Berlin, 23, pp. 802-870
4. Bodanszky, M. and Sheehan, J. T.: 1964, Chem. Ind. 1423-1424
5. Chan W. Y., Wo N. C., Stoev S., Cheng L. L., Manning M. (1998a) Br. J. Pharmacol. 125(4): 803-811
6. Chan W. Y., Wo N. C., Stoev S., Cheng L. L., Manning M. (1998b) Adv. Exp. Med. Biol. 449: 451-453
7. Chan W. Y., Wo N. C., Stoev S. B., Cheng L. L., Manning M. (2000) Exp. Physiol. 85: 7S-18S
8. Chan W. Y., Levi R., Wo N. C., Koyama M., Stoev S., Cheng L. L., Manning M. (2001) Eur. J. Pharmacol. 419(1): 65-72
9. Cheng, L. L., Stoev, S., Manning, M., Wo, N. C. and Chan, W. Y.: 2001, in M. Lebl and R. A. Houghten (eds.), Peptides: The Wave of the Future. American Peptide Society, San Diego, pp. 978-979
10. Cheng L. L., Stoev S., Manning M., Derick S., Pena A., Ben Mimoun M., Guillon G. (2004) J. Med. Chem. 47(9): 2375-88
11. Cheng, L. L., Stoev, S., Manning, M., Wo, N. C. and Szeto, H. H.: 2006, in K. Rolka, P. Rekowski and J. Silberring (eds.), Peptides 2006, Kenes International, Geneva, Switzerland (in press)
12. Dekanski J. (1952) Br. J. Pharmacol. 7(4): 567-572
13. du Vigneaud V., Gish. D. T., Katsoyannis P. G. (1954a) J. Am. Chem. Soc. 76: 4751-5752
14. du Vigneaud V., Ressler C., Swan J. M., Katsoyannis P. G. (1954b) J. Am. Chem. Soc. 76: 3115-3121
15. Glass J. D., du Vigneaud V. (1973) J. Med. Chem. 16(2): 160-161
16. Hirsch A. T., Dzau V. J., Majzoub J. A., Creager M. A. (1989) J. Clin. Invest. 84(2): 418-426
17. Holton P. (1948) Br. J. Pharmacol. 3: 328-334
18. Hope D. B., Murti V. V., du Vigneaud V. (1962) J. Biol. Chem. 237: 1563-1566
19. Hruby, V. J. and Smith, C. J.: 1987, in S. Udenfriend and J. Meienhofer, J. (eds.), The Peptides, Analysis, Chemistry, Biology, Vol. 8. C. W. Smith (Ed). Chemistry, Biology and Medicine of Neurohypophyseal Hormones and their Analogs, Academic Press, Orlando, Florida, pp. 177-207
20. Jard, S.: 1998, in H. H. Zingg, C. W. Bourque and D. G. Bichet (eds.), Advances in Experimental Medicine and Biology, Adv. Exp. Med Biol., Plenum Press, New York, pp. 1-13
21. Katusic Z. S., Shepherd J. T., Vanhoutte P. M. (1984) Circ. Res. 55(5): 575-579
22. Kolodziejczyk A. M., Manning M. (1981) J. Org. Chem. 46: 1944-1946
23. Konig W., Geiger R. (1970) Chem. Ber. 103(3): 788-798
24. Kruszynski M., Lammek B., Manning M., Seto J., Haldar J., Sawyer W. H. (1980) J. Med. Chem. 23(4): 364-368
25. Lebl, M.: 1987, in K. Jost, M. Lebl and F. Brtnik (eds.), Handbook of Experimental Pharmacology, Vol. 2, Part 1. CRC Press, Boca Raton FL, pp. 17-74
26. Lebl, M., Jost, K. and Brtnik, F.: 1987, in K. Jost, M. Lebl and F. Brtnik (eds.), Handbook of Experimental Pharmacology, Vol. 2, Part 2. CRC Press, Boca Raton FL, pp. 127-267
27. Liard J. F. (1989) Am. J. Physiol. Heart Circ. Physiol. 256: 1621-1626
28. Manning M., du Vigneud V. (1965) J. Am. Chem. Soc. 87: 3978-3983
29. Manning M. (1968) J. Am. Chem. Soc. 90(5): 1348-1349
30. Manning M., Wuu T. C., Baxter J. W. (1968) J. Chromatogr. 38(3): 396-398
31. Manning M., Lammek B., Kolodziejczyk A. M., Seto J., Sawyer W. H. (1981) J. Med. Chem. 24(6): 701-706
32. Manning M., Olma A., Klis W. A., Kolodziejczyk A. M., Seto J., Sawyer W. H. (1982) J. Med. Chem. 25(1): 45-50
33. Manning M., Nawrocka E., Misicka A., Olma A., Klis W. A., Seto J., Sawyer W. H. (1984) J. Med. Chem. 27(4): 423-429
34. Manning M., Misicka A., Olma A., Klis W. A., Bankowski K., Nawrocka E., Kruszynski M., Kolodziejczyk A., Cheng L. L., Seto J., Wo N. C., Sawyer W. H. (1987a) J. Med. Chem. 30(12): 2245-2252
35. Manning M., Przybylski J. P., Olma A., Klis W. A., Kruszynski M., Wo N. C., Pelton G. H., Sawyer W. H. (1987b) Nature 329: 839-840
36. Manning M., Sawyer W. H. (1989) J. Lab. Clin. Med. 114(6): 617-632
37. Manning M., Przybylski J., Grzonka Z., Nawrocka E., Lammek B., Misicka A., Cheng L. L., Chan W. Y., Wo N. C., Sawyer W. H. (1992) J. Med. Chem. 35(21): 3895-3904
38. Manning M., Sawyer W. H. (1993) J. Receptor Res. 13(1-4): 195-214
39. Manning, M., Cheng, L. L., Klis, W. A., Stoev, S., Przybylski, J., Bankowski, K., Sawyer, W. H. and Chan, W. Y.: 1995, in R. Ivell and J. Russell (eds.), Oxytocin: Cellular and Molecular Approaches in Medicine and Research, Plenum Press, New York, NY, pp. 559-583
40. Manning M., Cheng L. L., Stoev S., Klis W. A., Nawrocka E., Olma A., Sawyer W. H., Wo N. C., Chan W. Y. (1997) J. Peptide Sci. 3(1): 31-46
41. Manning, M., Stoev, S., Cheng, L. L., Wo, N. C. and Chan, W. Y.: 1998, in R. Ramage and R. Epton (eds.), Peptides 1996. Mayflower Scientific Ltd., England, pp. 615-616
42. Manning M., Stoev S., Cheng L. L., Wo N. C., Chan W. Y. (1999a) J. Receptor Signal Transduction Res. 19(1-4): 631-644
43. Manning M., Stoev S., Cheng L. L., Wo N. C., Chan W. Y. (1999b) J. Peptide Sci. 5(11): 472-490
44. Manning, M., Stoev, S., Cheng, L. L., Wo, N. C. and Chan, W. Y. 1999c, in S. Bajusz and F. Hudecz (eds.), Peptides 1998. Akademia Kiado, Budapest, Hungary, pp. 56-57
45. Merrifield B. (1963) J. Am. Chem. Soc. 85: 2149-2154
46. Merrifield B. (1964) Biochemistry 3: 1385-1390
47. Munsick R.A. (1960) Endocrinology 6: 451-457
48. Rivier J., Kaiser R., Galyean R. (1978) Biopolymers 17: 1927-1938
49. Rawls R. (2003) Chem. Eng. News 81: 54-57
50. Sawyer W. H. (1961) Methods Med. Res. 9: 210-219
51. Sawyer W. H., Bankowski K., Misicka A., Nawrocka E., Kruszynski M., Stoev S., Klis W. A., Przybylski J. P., Manning M. (1988) Peptides 9: 157-163
52. Schild H. O. (1958) Br. J. Pharmacol. Chemother. 2: 189-206
53. Stang, P. J.: 2003, J. Am. Chem. Soc. 125, 1-8
54. Stewart J. M., Young J. D. (1984) Solid Phase Synthesis. Pierce Chemical Company, Rockford, IL
55. Stoev, S., Cheng, L. L., Manning, M., Wo, N. C. and Szeto, H. H.: 2005, in M. Flegel, M. Fritkin, C. Gilon and J. Slaninova (eds.), Peptides 2004. Kenes International, Geneva, Switzerland, pp. 904-905
56. Stoev S., Cheng L. L., Manning M., Wo N. C., Szeto H. H. (2006) J. Peptide Sci. 12(9): 592-604
57. Tabrizchi R., Ford C. A. (2004) Naunyn Schmiedebergs Arch. Pharmacol. 370(5): 340-346
58. Takashima H., du Vigneaud V., Merrifield R. B. (1968) J. Am. Chem. Soc. 90(5): 1323-1325
59. Yu M., Ghosh M., McNeill J. R. (2003) Can. J. Physiol. Pharmacol. 81(5): 497-501